White House official dings Bristol Myers Squibb for fighting off generic competition

WASHINGTON — A top White House official on Tuesday delivered a pointed attack at a drugmaker fighting the administration’s Medicare negotiation plan in court.

Christen Linke Young, White House Domestic Policy Council’s deputy assistant to the president for health and veterans affairs, took on Bristol Myers Squibb, which makes the blockbuster blood thinner Eliquis. Eliquis is one of 10 high-cost drugs the federal program has targeted first for negotiated prices.

“The manufacturer of that drug spent most of 2020 in court trying to fend off generic competition,” she said at a Tuesday STAT event here. Generic drugmakers sued BMS in 2019 to challenge the drug’s patents.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In